Data as of Dec 26
| -0.01 / -1.54%|
The 2 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 1.45, with a high estimate of 1.90 and a low estimate of 1.00. The median estimate represents a +126.56% increase from the last price of 0.64.
The current consensus among 2 polled investment analysts is to Buy stock in NovaBay Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.